Lawrence F. Eichenfield

Guest Editor for the following articles:

Sep
2017
Vol. 36. No. 3

Diagnosis, comorbidity, and psychosocial impact of atopic dermatitis

Andrea Waldman, MD | Dawn Marie Davis, MD | Jennifer LeBovidge, PhD | Jonathan Spergel, PhD | Jusleen Ahluwalia, MD | Megha M Tollefson, MD | Nathan Jetter, BS | Sharon E Jacob, MD
Understanding both the clinical characteristics and implications of AD is critical to lessening the psychosocial, clinical, and economic burden of this disease.
MORE
Dec
2001
Vol. 20. No. 4

Pathophysiologic Mechanisms in Atopic Dermatitis

Donald YM Leung, PhD | Mark Boguniewicz, MD

This article examines theĀ  pathophysiologic mechanisms involved in atopic dermatitis. An understanding of these mechanisms is critical for developing new treatment strategies for this increasingly common illness.

MORE
Mar
2017
Vol. 36. No. 2

Practical Strategies for the Diagnosis and Assessment of Atopic Dermatitis

Lawrence F. Eichenfield, MD | Linda Stein Gold, MD

Atopic dermatitis (AD) has a significant, lifelong clinical impact on affected individuals and has profound effects on quality of life both for patients and their families.

If you would like to complete the CME portion of this Supplement, please click here.

MORE
Mar
2017
Vol. 36. No. 2

Atopic Dermatitis Progression: Evaluating Intervention Strategies

Lawrence F. Eichenfield, MD | Linda Stein Gold, MD

Several risk factors have been identified that appear to be consistently and strongly associated with the development of atopic dermatitis (AD): a family history of atopy, an inherited genetic predisposition, and active and passive exposure to tobacco smoke.

If you would like to complete the CME portion of this Supplement, please click here.

MORE
Sep
2017
Vol. 36. No. 3

Atopic dermatitis: pathogenesis

Andrea Waldman, MD | Emma Guttman-Yassky, MD | Jusleen Ahluwalia, MD | Lawrence F. Eichenfield, MD | Peck Y Ong, MD
This article details the pathogenesis section of the Curriculum United for Better Eczema Care (CUBE-C), facilitating primary care and sub-specialist education on the scientific advances driving recent AD therapeutic innovations.
MORE